C Kahl

M Pouyiourou 1 collaboration

A Meyer 1 collaboration

A Stroux 1 collaboration

A Viardot 1 collaboration

P La Rosée 1 collaboration

G Maschmeyer 1 collaboration

D Kämpfe 1 collaboration

V Vucinic 1 collaboration

A Monecke 1 collaboration

C Hirt 1 collaboration

T Weber 1 collaboration

J Meissner 1 collaboration

M Witzens-Harig 1 collaboration

S Böttcher 1 collaboration

H Schmalenberg 1 collaboration

R Marks 1 collaboration

G Prange-Krex 1 collaboration

F Kroschinsky 1 collaboration

E Hauf 1 collaboration

U Keller 1 collaboration

K Koch 1 collaboration

W Klapper 1 collaboration

M Herold 1 collaboration

Christian W Scholz 1 collaboration

None None 1 collaboration

Arndt Stahler 1 collaboration

Sebastian Stintzing 1 collaboration

Jobst C von Einem 1 collaboration

Christoph B Westphalen 1 collaboration

Kathrin Heinrich 1 collaboration

Nicole Krämer 1 collaboration

Marlies Michl 1 collaboration

Dominik P Modest 1 collaboration

Ludwig Fischer von Weikersthal 1 collaboration

Thomas Decker 1 collaboration

Alexander Kiani 1 collaboration

Tobias Heintges 1 collaboration

Christoph Kahl 1 collaboration

Frank Kullmann 1 collaboration

Werner Scheithauer 1 collaboration

Markus Moehler 1 collaboration

Florian Kaiser 1 collaboration

Thomas Kirchner 1 collaboration

Andreas Jung 1 collaboration

Volker Heinemann 1 collaboration

Affiliations

Publications (2)

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis.

Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.

Réseau de co-auteurs